Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
Background Familial hypercholesterolemia (FH) may arise from deleterious monogenic variants in FH‐causing genes as well as from a polygenic cause. We evaluated the relationships between monogenic FH and polygenic hypercholesterolemia in influencing the long‐term response to therapy and the risk of a...
Main Authors: | Laura D’Erasmo, Ilenia Minicocci, Alessia Di Costanzo, Giovanni Pigna, Daniela Commodari, Fabrizio Ceci, Anna Montali, Francesca Brancato, Ilaria Stanca, Antonio Nicolucci, Andrea Ascione, Nicola Galea, Iacopo Carbone, Marco Francone, Marianna Maranghi, Marcello Arca |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.120.018932 |
Similar Items
-
Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
by: Agnieszka Mickiewicz, et al.
Published: (2020-05-01) -
Family and polygenic hypercholesterolemia: similarities and differencies by long-term follow-up
by: B M Lipovetskiy, et al.
Published: (2009-03-01) -
A polygenic biomarker to identify patients with severe hypercholesterolemia of polygenic origin
by: Luis G. Leal, et al.
Published: (2020-06-01) -
Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
by: Isabella Ramos Lima, et al.
Published: (2022-08-01) -
Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
by: Timothy Lee, BSc, et al.
Published: (2019-05-01)